Latest Market Share News

Eden Innovations reports a remarkable surge in US OptiBlend kit orders, with recent two-week sales nearly matching last year’s full annual total. This growth underscores rising demand from data centres seeking cost-effective, lower-emission backup power solutions.

One Click Group reported a robust September quarter with $1.6 million positive operating cash flow and 27% revenue growth, fueled by strong user acquisition and a new cash advance product rollout.

Wisr has reported a robust start to FY26, with loan originations soaring 90% year-on-year and a 15% expansion in its loan book, supported by improved credit quality and a solid capital position.

OFX Group reports solid progress in migrating corporate clients to its new platform, OFX 2.0, despite a decline in net operating income driven by macroeconomic uncertainty. The fintech’s strategic product launches and client growth signal potential for recovery.

Kinatico Limited reported a robust start to FY26, with SaaS revenue surging 58% and a fresh marketing campaign aimed at SMBs and enterprises. The company balances growth with profitability, setting the stage for international expansion.

Boom Logistics reports steady revenue growth and significant capital expenditure cuts in Q1 FY26, while advancing a share buyback and navigating leadership changes.

Amotiv Limited reported steady FY25 financials with marginal revenue growth and a slight EBITA dip, while unveiling its ambitious Amotiv2030 strategy to drive future shareholder value amid ongoing market challenges.

FINEOS Corporation Holdings PLC reports solid Q3 2025 results, highlighting revenue growth, operational efficiencies, and a key North American client migration to its SaaS platform, underpinning positive free cash flow expectations for FY25.

Cuscal Limited has secured a crucial regulatory win as the ACCC clears its full acquisition of Indue Limited, setting the stage for completion by year-end pending final approvals.

Salter Brothers Emerging Companies Limited has announced a further 12-month extension of its on-market share buy-back program, allowing the company to repurchase up to 8.45 million shares to maintain capital management flexibility and enhance shareholder value.

Australian Clinical Labs has announced a 12-month on-market share buy-back program targeting up to 10% of its shares, aiming to enhance shareholder returns without compromising its financial strength.

WAM Strategic Value Limited has confirmed a fully franked final dividend of AUD 0.03 per share for the financial year ending June 2025, alongside an updated Dividend Reinvestment Plan price.